Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Ferrer

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Lipids in Health and Disease|February 10, 2026
The influence of ethnicity and sex on lipid profile and cardiovascular risk factors: a population-based studyAlejandra Pérez-Montes de Oca, Analía Ramos, Anna Hernández-Rubio, et al.
Viruses|June 27, 2024
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope GlycoproteinRaquel Ortiz, Ana Barajas, Anna Pons-Grífols, et al.
Vaccine|July 17, 2023
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidateAlexandra Moros, Antoni Prenafeta, Antonio Barreiro, et al.
The Prostate|May 3, 2026
Non-Cancer Causes of Death in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World AnalysisMarta Garcia de Herreros, Clara Rodrigo, Laura Ferrer-Mileo, et al.
European Urology Open Science|June 18, 2025
Corrigendum to "Prognostic Expression Signature of <i>RB1</i>, <i>PTEN</i>, and <i>TP53</i> Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors" [Eur. Urol. Open Sci. 70 (2024) 86-90]Marta Garcia de Herreros, Natalia Jiménez, Leonardo Rodríguez-Carunchio, et al.
Oncoimmunology|June 17, 2022
Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effectKef K Prasit, Laura Ferrer-Font, Olivia K Burn, et al.
European Urology Open Science|November 6, 2024
Prognostic Expression Signature of <i>RB1</i>, <i>PTEN</i>, and <i>TP53</i> Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway InhibitorsMarta Garcia de Herreros, Natalia Jiménez, Leonardo Rodríguez-Carunchio, et al.
Cancers|October 14, 2022
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and DocetaxelNatalia Jiménez, Òscar Reig, Mercedes Marín-Aguilera, et al.
Iscience|July 28, 2023
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primatesAntoni Prenafeta, Gregori Bech-Sàbat, Alexandra Moros, et al.
International Journal of Molecular Sciences|July 12, 2025
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN ExpressionMarta Garcia de Herreros, Natalia Jiménez, Joan Padrosa, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Lipids in Health and Disease|February 10, 2026
The influence of ethnicity and sex on lipid profile and cardiovascular risk factors: a population-based studyAlejandra Pérez-Montes de Oca, Analía Ramos, Anna Hernández-Rubio, et al.
Viruses|June 27, 2024
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope GlycoproteinRaquel Ortiz, Ana Barajas, Anna Pons-Grífols, et al.
Vaccine|July 17, 2023
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidateAlexandra Moros, Antoni Prenafeta, Antonio Barreiro, et al.
The Prostate|May 3, 2026
Non-Cancer Causes of Death in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World AnalysisMarta Garcia de Herreros, Clara Rodrigo, Laura Ferrer-Mileo, et al.
European Urology Open Science|June 18, 2025
Corrigendum to "Prognostic Expression Signature of <i>RB1</i>, <i>PTEN</i>, and <i>TP53</i> Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors" [Eur. Urol. Open Sci. 70 (2024) 86-90]Marta Garcia de Herreros, Natalia Jiménez, Leonardo Rodríguez-Carunchio, et al.
Oncoimmunology|June 17, 2022
Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effectKef K Prasit, Laura Ferrer-Font, Olivia K Burn, et al.
European Urology Open Science|November 6, 2024
Prognostic Expression Signature of <i>RB1</i>, <i>PTEN</i>, and <i>TP53</i> Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway InhibitorsMarta Garcia de Herreros, Natalia Jiménez, Leonardo Rodríguez-Carunchio, et al.
Cancers|October 14, 2022
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and DocetaxelNatalia Jiménez, Òscar Reig, Mercedes Marín-Aguilera, et al.
Iscience|July 28, 2023
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primatesAntoni Prenafeta, Gregori Bech-Sàbat, Alexandra Moros, et al.
International Journal of Molecular Sciences|July 12, 2025
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN ExpressionMarta Garcia de Herreros, Natalia Jiménez, Joan Padrosa, et al.
Pageof 12